Please login to the form below

Not currently logged in

John Brown to chair Cell Therapy Catapult

Will lead new UK centre to support biotech companies involved in cell therapy technology

TSB - John BrownDr John Brown has been appointed first chair of the Cell Therapy Catapult centre, a new initiative from the UK's Technology Strategy Board that focuses on the cell therapy industry.

He will lead the centre as it provides with access to finance, clinical and technical expertise to biotech companies involved in cell therapy technology in an aim to make the UK a global leader in the sector.

This includes helping to turn innovations in cell therapies into commercial products for use as medicines.

“This is an exciting time for the Cell Therapy Catapult, as it is only weeks away from opening its doors,” said minister for universities and science David Willetts.

“John Brown has a wealth of experience in running businesses in the life sciences sector, and the skills he can bring to the table are exactly what we need to help get this latest Catapult off the ground."

Dr Brown has great experience in the life sciences industry, holding such positions as chairman of medical diagnostics company Axis-Shield and chair of specialist healthcare company, BTG.

He has also spent time as CEO and finance director of UK vaccine company Acambis.

Dr Brown said: “The Cell Therapy Catapult will position the UK as the leader in this new area of medicine. Translating great science into products will deliver benefits both for patients but also our economy and I'm delighted to have the opportunity to build on the great foundation of work that the Technology Strategy Board has already done.”

His appointment was welcomed by the BioIndustry Association (BIA), of which Dr Brown is a board member.

"John's presence on our board and as chair of the Catapult will make sure that strong links are developed and maintained between the two organisations,” said Steve Bates, CEO of the BIA.

17th September 2012

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....